AVDL News and Press, Avadel Pharmaceuticals plc From 10/26/20

DUBLIN, Ireland, Oct. 26, 2020 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a company focused on developing FT218, an investigational, once-nightly formulation of sodium oxybate designed to treat excessive daytime sleepiness and cataplexy in patients with narcolepsy, annou...

Gainers: [[JAX]] +4.5%. [[AXGT]] +4.4%. [[HRI]] +3.1%. [[AVDL]] +2.3%. [[AAL]] +1.7%.Losers: [[TATT]] -6.2%. [[FNKO]] -3.5%. [[IMGN]] -3.0%. [[VIVO]] -2.6%. [[INMD]] -1.6%. For further details see: AXGT, AVDL, INMD and IMGN among after-hours movers

DUBLIN, Ireland, Sept. 17, 2020 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL) a company focused on developing FT218, an investigational, once-nightly formulation of sodium oxybate, today announced that its executive team will be presenting at the Oppenheimer Fall Health...

Jordan Dubow, M.D. stepping down as CMO and will continue as a consultant to the Company through the FT218 NDA submission and review Seasoned industry veteran and Avadel Board member, Mark McCamish, M.D., Ph.D., to work with management and provide direct leadership of the FT218 progra...

DUBLIN, Ireland, Sept. 11, 2020 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL) a company focused on developing FT218, an investigational, once-nightly formulation of sodium oxybate, today announced that its executive team will be presenting at the H.C. Wainwright 22 nd ...

Quick Take Harmony Biosciences Holdings ( HRMY ) intends to raise $100 million from the sale of its common stock in an IPO, according to an amended registration statement. The company is advancing development and commercialization of narcolepsy and related treatments. HRMY has shown a st...

Image source: The Motley Fool. Avadel Pharmaceuticals plc   (NASDAQ: AVDL) Q2 2020 Earnings Call Aug 10, 2020 , 8:30 a.m. ET Operator Continue reading

Avadel Pharmaceuticals plc (AVDL) Q2 2020 Earnings Conference Call August 10, 2020 08:30 ET Company Participants Thomas McHugh - Chief Financial Officer Greg Divis - Chief Executive Officer Jordan Dubow - Chief Medical Officer Conference Call Participants Ami Fadia - Leerin...

Avadel Pharmaceuticals (NASDAQ: AVDL ) : Q2 EPS of $0.49 may not be comparable to consensus of -$0.10. More news on: Avadel Pharmaceuticals plc, Earnings news and commentary, Healthcare stocks news, Read more ...

Presented positive topline data from the pivotal Phase 3 REST-ON study Announced today that results of the data analyses for the secondary endpoints of the REST-ON study were consistent with the primary analyses and further demonstrated the overall statistical significance of FT218 co...